HealthcareServices

Generalized Anxiety Disorder Market Anticipated to Record Steady Gains, Advancing to $9.71 Billion by 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the generalized anxiety disorder market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Generalized Anxiety Disorder Market?

The generalized anxiety disorder market has experienced consistent expansion in recent years. It is anticipated to expand from $7.93 billion in 2025 to $8.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.2%. This historical growth can be ascribed to factors including increasing mental health awareness, the widespread availability of antidepressants, the expansion of psychiatric services, prevalent societal stress factors, and enhanced primary care diagnosis.

The generalized anxiety disorder market size is anticipated to undergo steady expansion over the next few years, projected to reach $9.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.4%. This growth in the forecast period can be attributed to several factors including the rise of digital therapeutics, increased demand for personalized mental healthcare, broader adoption of telehealth services, a stronger focus on preventive mental health, and innovations within neuromodulation therapies. Significant trends for this period encompass a growing acceptance of cognitive behavioral therapy, a heightened reliance on pharmacological anxiety treatments, the proliferation of digital mental health platforms, the expansion of remote and telepsychiatry services, and increased awareness surrounding mental health disorders.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13039&type=smp

What Drivers Are Supporting Technological Adoption In The Generalized Anxiety Disorder Market?

The increasing prevalence of mental disorder cases within the healthcare industry is propelling the expansion of the generalized anxiety disorder market. A mental disorder, also known as a mental illness, covers a broad spectrum of conditions that impact a person’s thoughts, emotions, behaviors, and overall mental well-being. Mental health disorders often accompanying generalized anxiety disorder include phobias, panic disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD), and effectively managing these conditions is essential for individuals to sustain healthy relationships and improve their quality of life. For instance, according to the Stress in America 2023 survey published by the American Psychological Association, a US-based professional organization, in November 2023, adults aged 35 to 44 experienced the highest rise in mental health diagnoses, with 45% reporting a mental illness in 2023 compared with 31%. Despite this, adults ages 18 to 34 still reported the highest rate of mental illnesses at 50% in 2023. Hence, the rising number of mental disorder cases is expected to stimulate the growth of the generalized anxiety disorder market.

Which Segments Are Contributing To The Growth Of The Generalized Anxiety Disorder Market?

The generalized anxiety disorder market covered in this report is segmented –

1) By Type: Panic Disorder, Agoraphobia, Generalized Anxiety, Social Anxiety, Specific Phobia, Other Types

2) By Therapies: Interpersonal Therapy, Behavior Therapy, Cognitive Behavioral Therapy, Mindfulness Based Cognitive Therapy

3) By Device: Deep Brain Stimulation, Electroconvulsive Therapy, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Panic Disorder: Recurrent Panic Attacks, Unexpected Panic Attacks

2) By Agoraphobia: Situational Phobia, Open Spaces Anxiety

3) By Generalized Anxiety: Chronic Worry, Excessive Anxiety

4) By Social Anxiety: Performance Anxiety, Interaction Anxiety

5) By Specific Phobia: Animal Phobia, Environmental Phobia, Situational Phobia

6) By Other Type: Separation Anxiety Disorder, Selective Mutism, Post-Traumatic Stress Disorder (PTSD)

Which Trends Are Shaping Activity Within The Generalized Anxiety Disorder Market?

Leading companies in the generalized anxiety disorder market are developing and securing approval for innovative drugs such as MM-120 to better address the needs of their current consumers. Such novel medications, including MM-120, aim to enhance the management and outcomes of this mental health condition. For instance, in September 2023, Mind Medicine Inc. (MindMed), a U.S.-based biotech company focused on psychedelic-inspired therapies, completed enrollment for its Phase 2b trial of MM 120 (lysergide D-tartrate) for generalized anxiety disorder (GAD). With this milestone, MindMed intends to generate robust efficacy and safety data to support the continued development of MM 120 as a new treatment option for GAD. MM 120 functions as a small-molecule partial agonist of the 5 HT2A receptor, designed to enhance neuroplasticity and serotonin signaling to improve mood and anxiety, and it demonstrated a dose-dependent reduction in anxiety symptoms during the trial.

Who Are The Prominent Global Companies Shaping The Generalized Anxiety Disorder Market Landscape?

Major companies operating in the generalized anxiety disorder market are Alkermes plc, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline plc, Johnson And Johnson Private Limited, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Forest Laboratories Inc., H. Lundbeck A/S, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Mind Medicine Inc., Sage Therapeutics Inc., VistaGen Therapeutics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Which Region Is Projected To Lead The Generalized Anxiety Disorder Market During The Forecast Period?

North America was the largest region in the generalized anxiety disorder market in 2025. The regions covered in the generalized anxiety disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Generalized Anxiety Disorder Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13039&type=smp

Browse Through More Reports Similar to the Global Generalized Anxiety Disorder Market 2026, By The Business Research Company

Behavioral Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/behavioral-therapy-global-market-report

Panic Disorders Market Report 2026

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Major Depressive Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795